Disrupting the EMMPRIN (CD147)–Cyclophilin A Interaction Reduces Infarct Size and Preserves Systolic Function After Myocardial Ischemia and Reperfusion
Peter Seizer(University of Tübingen), Andreas E. May(Kernkraftwerk Gundremmingen), Reinhard Kandolf(Universitätsklinikum Tübingen), Oliver Borst(Thrombosis Research Institute), Carmen Ochmann(University of Illinois Urbana-Champaign), Karin Klingel(Universitätsklinikum Tübingen), Tanja Schönberger(University of Tübingen), Sebastian Zach(University of Illinois Urbana-Champaign), Stefan Engelhardt(Heidelberg University), Meinrad Gawaz(University of Tübingen), Florian Läng(University of Duisburg-Essen), Melanie Rose(University of Illinois Urbana-Champaign), Romana A. Nowak(University of Illinois Urbana-Champaign), H. Robson MacDonald(Hospital for Sick Children)
Cited by 113
Related Papers
Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
|European Heart Journal|2013|3.4k
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
|Nature|2008|2.4k
Skepinone-L, a Novel Potent and Highly Selective Inhibitor of p38 MAP Kinase, Effectively Impairs Platelet Activation and Thrombus Formation
|Cellular Physiology and Biochemistry|2013|1.9k
Cardiac fibroblast–derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy
|Journal of Clinical Investigation|2014|993